Protagonist Therapeutics Inc buy Citigroup Inc.
Start price
10.11.25
/
50%
€74.00
Target price
10.11.26
€84.79
Performance (%)
2.03%
Price
23.12.25
€75.50
Summary
This prediction is currently active. With a performance of 2.03%, the BUY prediction by Citigroup_Inc_ for Protagonist Therapeutics Inc is trending in the right direction. This prediction currently runs until 10.11.26. The prediction end date can be changed by Citigroup_Inc_ at any time. Citigroup_Inc_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Protagonist Therapeutics Inc | -3.205% | -3.205% |
| iShares Core DAX® | 0.765% | 4.791% |
| iShares Nasdaq 100 | 1.418% | 3.133% |
| iShares Nikkei 225® | 0.658% | 0.972% |
| iShares S&P 500 | 1.310% | 2.279% |
Comments by Citigroup_Inc_ for this prediction
In the thread Protagonist Therapeutics Inc diskutieren
Protagonist Therapeutics (NASDAQ:PTGX) had its price target raised by analysts at Citigroup Inc. from $96.00 to $98.00. They now have a "buy" rating on the stock.
Ratings data for PTGX provided by MarketBeat
Stopped prediction by Citigroup_Inc_ for Protagonist Therapeutics Inc
Protagonist Therapeutics Inc
Start price
Target price
Perf. (%)
€43.60
07.08.25
07.08.25
-
07.08.26
07.08.26
73.17%
23.12.25
23.12.25
Protagonist Therapeutics Inc
Start price
Target price
Perf. (%)
€46.40
17.06.25
17.06.25
€62.32
17.06.26
17.06.26
62.72%
23.12.25
23.12.25